BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15919785)

  • 21. Temporal pattern of pancreatic insulin and C-peptide secretion and of plasma glucose levels after nutritional stimulation.
    Balks HJ; Schmidt A; Prank K; Hemmer F; von zur Mühlen A; Brabant G
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1198-203. PubMed ID: 1430079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
    Polonsky KS; Given BD; Van Cauter E
    J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension.
    Piccardo MG; Turchetti G; Rosa MS; Pacini G
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):244-9. PubMed ID: 10656171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein.
    Matveyenko AV; Veldhuis JD; Butler PC
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E569-74. PubMed ID: 18577690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fasting on physiologically pulsatile insulin release in healthy humans.
    Juhl C; Grøfte T; Butler PC; Veldhuis JD; Schmitz O; Pørksen N
    Diabetes; 2002 Feb; 51 Suppl 1():S255-7. PubMed ID: 11815488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by proinsulin of endogenous C-peptide release in healthy man.
    Waldhäusl WK; Bratusch-Marrain P; Gasić S; Komjati M; Heding L
    Am J Physiol; 1986 Aug; 251(2 Pt 1):E139-45. PubMed ID: 3526918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion.
    Sturis J; Van Cauter E; Blackman JD; Polonsky KS
    J Clin Invest; 1991 Feb; 87(2):439-45. PubMed ID: 1991830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
    Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
    J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs.
    Harding PE; Bloom G; Field JB
    Am J Physiol; 1975 May; 228(5):1580-8. PubMed ID: 1130563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects.
    Kautzky-Willer A; Thomaseth K; Clodi M; Ludvik B; Waldhäusl W; Prager R; Pacini G
    Metabolism; 1996 Apr; 45(4):486-91. PubMed ID: 8609836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.
    Shah P; Vella A; Basu A; Basu R; Adkins A; Schwenk WF; Johnson CM; Nair KS; Jensen MD; Rizza RA
    Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.
    Juhl CB; Pørksen N; Hollingdal M; Sturis J; Pincus S; Veldhuis JD; Dejgaard A; Schmitz O
    Diabetes Care; 2000 May; 23(5):675-81. PubMed ID: 10834429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.
    Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A
    Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.
    Juhl CB; Schmitz O; Pincus S; Holst JJ; Veldhuis J; Pørksen N
    Diabetologia; 2000 May; 43(5):583-8. PubMed ID: 10855533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pancreas transplantation on postprandial glucose metabolism.
    Katz H; Homan M; Velosa J; Robertson P; Rizza R
    N Engl J Med; 1991 Oct; 325(18):1278-83. PubMed ID: 1922222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.
    Chap Z; Ishida T; Chou J; Hartley CJ; Lewis RM; Entman M; Field JB
    J Clin Invest; 1985 Dec; 76(6):2222-34. PubMed ID: 3908485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.